395 related articles for article (PubMed ID: 22169682)
21. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease.
Schmidt A; Ulrich M; Winkler B; Klaeffling C; Bausback Y; Bräunlich S; Botsios S; Kruse HJ; Varcoe RL; Kum S; Scheinert D
Catheter Cardiovasc Interv; 2010 Dec; 76(7):1047-54. PubMed ID: 20518006
[TBL] [Abstract][Full Text] [Related]
22. Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial.
Lansky AJ; Ng VG; Mutlu H; Cristea E; Guiran JB; Midei M; Newman W; Sanz M; Sood P; Doostzadeh J; Su X; White R; Cao S; Sudhir K; Stone GW
Catheter Cardiovasc Interv; 2009 Nov; 74(5):719-27. PubMed ID: 19530147
[TBL] [Abstract][Full Text] [Related]
23. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
[TBL] [Abstract][Full Text] [Related]
24. Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.
Fusaro M; Cassese S; Ndrepepa G; Tepe G; King L; Ott I; Nerad M; Schunkert H; Kastrati A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1284-93. PubMed ID: 24355118
[TBL] [Abstract][Full Text] [Related]
25. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study.
Siablis D; Kraniotis P; Karnabatidis D; Kagadis GC; Katsanos K; Tsolakis J
J Endovasc Ther; 2005 Dec; 12(6):685-95. PubMed ID: 16363898
[TBL] [Abstract][Full Text] [Related]
26. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
[TBL] [Abstract][Full Text] [Related]
27. Bare nitinol stent enabled recanalization of long-segment, chronic total occlusion of superficial femoral and adjacent proximal popliteal artery in diabetic patients presenting with critical limb ischemia.
Taneja M; Tay KH; Dewan A; Sebastian MG; Pasupathy S; Lin SE; Teo T; Lo R; Tan SG; Irani FG; Tan BS
Cardiovasc Revasc Med; 2010; 11(4):232-5. PubMed ID: 20934655
[TBL] [Abstract][Full Text] [Related]
28. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
29. Drug-eluting stents for treatment of focal infrapopliteal lesions.
Rastan A; Noory E; Zeller T
Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.
Balzer JO; Zeller T; Rastan A; Sixt S; Vogl TJ; Lehnert T; Khan V
J Cardiovasc Surg (Torino); 2010 Apr; 51(2):183-91. PubMed ID: 20354488
[TBL] [Abstract][Full Text] [Related]
31. Drug-eluting tibial stents: objective patency determination.
McMillan WD; Leville CD; Long TD; Gomes M; Groffsky JL; Schultz SR
J Vasc Interv Radiol; 2010 Dec; 21(12):1825-9. PubMed ID: 20961774
[TBL] [Abstract][Full Text] [Related]
32. One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients.
Taeymans K; Bosiers M; Deloose K; Callaert J; Keirse K; Verbist J; van den Eynde W; Torsello G; Wauters J
J Cardiovasc Surg (Torino); 2020 Aug; 61(4):445-450. PubMed ID: 30994307
[TBL] [Abstract][Full Text] [Related]
33. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
34. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
[TBL] [Abstract][Full Text] [Related]
35. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
36. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
39. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score.
Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B
J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147
[TBL] [Abstract][Full Text] [Related]
40. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
Huntress LA; Fereydooni A; Dardik A; Nassiri N
Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
